While mangrove ecosystems are rich in biodiversity, they are increasingly impacted by climate change and urban pollutants. The current study provides first insights into the emergence of potentially pathogenic yeasts in Hong Kong’s mangroves. Sediment and water samples were collected from ten urban and rural mangroves sites. Initial CHROMagarTM Candida Plus screening, representing the first application of this differential medium for water and soil samples collected from a non-clinical environment, enabled the rapid, preliminary phenotypic identification of yeast isolates from mangroves. Subsequent molecular profiling (ITS and/or 28S nrDNA sequencing) and antifungal drug susceptibility tests were conducted to further elucidate yeast diversity and drug resistance. A diversity of yeasts, including 45 isolates of 18 distinct species across 13 genera/clades, was isolated from sediments and waters from Hong Kong mangroves. Molecular profiling revealed a dominance of the Candida/Lodderomyces clade (44.4%), a group of notorious opportunistic pathogens. The findings also reveal a rich biodiversity of non-Candida/Lodderomyces yeasts in mangroves, including the first reported presence of Apiotrichum domesticum and Crinitomyces flavificans. A potentially novel Yamadazyma species was also discovered. Remarkably, 14.3% of the ubiquitous Candida parapsilosis isolates displayed resistance to multiple antifungal drugs, suggesting that mangroves may be reservoirs of multi-drug resistance. Wildlife, especially migratory birds, may disseminate these hidden threats. With significant knowledge gaps regarding the environmental origins, drug resistance, and public health impacts of pathogenic yeasts, urgent surveillance is needed from a One Health perspective. This study provides an early warning that unrestrained urbanization can unleash resistant pathogens from coastal ecosystems globally. It underscores the necessity for enhanced surveillance studies and interdisciplinary collaboration between clinicians, ornithologists, and environmental microbiologists to effectively monitor and manage this environmental health risk, ensuring the maintenance of ‘One Health’.
Zika virus (ZIKV) is an emerging flavivirus primarily transmitted by Aedes mosquitoes. It has gained significant attention due to its potential teratogenic effects during pregnancy, particularly the increased risk of severe congenital outcomes such as microcephaly and fetal mortality. ZIKV's ability to breach the fetal-maternal interface and compromise placental function distinguishes it from other arboviruses. This mini-review explores how ZIKV targets key placental cells, including cytotrophoblasts, extravillous trophoblasts, syncytiotrophoblasts, and Hofbauer cells, to establish infection in the placenta. We first explore the molecular mechanisms of ZIKV replication, focusing on viral entry, replication strategies, and evasion of host immunity in trophoblasts. We then discuss how ZIKV infection triggers cellular stress responses, such as oxidative stress, endoplasmic reticulum stress, and inflammatory pathways, along with metabolic reprogramming. These processes ultimately lead to placental insufficiency and adverse pregnancy outcomes. Drawing on recent findings from trophoblast organoids and in vivo models, we highlight novel therapeutic opportunities, including vasoactive intestinal peptide, endoplasmic reticulum stress modulators, and immunomodulatory interventions that may protect pregnancy. Finally, we propose future directions for mitigating ZIKV's impact on maternal-fetal health, emphasizing the need for comprehensive research into viral pathogenesis, advanced model systems, and vector control programs to prevent this devastating infection.
Talaromyces marneffei is a dimorphic fungus that transitions from a filamentous form at 25 °C to a pathogenic yeast form at 37 °C, demonstrating pathogenicity mostly in immunocompromised individuals, such as those with human immunodeficiency virus/AIDS. Though it is one of the most severe infectious fungi in Southeast Asia, the lack of comprehensive genomic analysis has hindered advancement in strain differentiation, diagnosis and treatment. In this study, we assembled a high-quality genome of T. marneffei ATCC 18224, resulting in a 28.9 Mb genome distributed across 11 contigs, using third-generation Oxford Nanopore Technologies sequencing reads. Notably, we identified a strain-specific 740-kb segmental duplication in strain ATCC 18224, potentially mediated by inserting a Ty1/ Copia long terminal repeat (LTR) retrotransposon. This segmental duplication includes various functional genes, with 75 differentially expressed during its dimorphic transition. Comparative genomic analysis revealed large-scale rearrangements in strains PM1 and 11CN-20-091, which were inconsistent with the phylogenomic trees of six T. marneffei strains and required further investigation. Additionally, we observed substantial genetic structural variations in LTR retrotransposons, particularly within the Ty1/ Copia family, including two significant recent expansions in strain ATCC 18224. In summary, the identification and characterization of these extensive genomic structural variations in T. marneffei contribute to a deep understanding of its genetic diversity and will facilitate improvements in genotyping, classification and genomic surveillance.
The genus Sarocladium comprises fungal species closely related to Acremonium, with S. kiliense and S. strictum being medically important. These species can cause infections in both immunocompetent and immunocompromised individuals. The current detection methods are limited, prompting the need for rapid and specific diagnostic tools. We developed a colorimetric loop-mediated isothermal amplification (LAMP) assay targeting S. kiliense (SK-LAMP). The initial prototype assay faced challenges with cross-reactivities with closely related species. To address this, we incorporated two additives, pullulan and tetramethylammonium chloride (TMAC), which are known to reduce non-specific signals in amplification assays. Our study found that a combination of 1% (v/v) pullulan and 0.03 M TMAC enhanced the specific detection of S. kiliense in a 45 min reaction, without non-specific false-positive results for other fungal species. This optimised LAMP assay demonstrated high sensitivity and specificity, offering a reliable and rapid method for detecting S. kiliense. The novel approach of combining additives to enhance assay specificity presents a promising strategy for improving LAMP assays targeting closely related fungal species. This advancement can aid in the timely diagnosis and management of infections caused by S. kiliense, contributing to better patient outcomes and infection control.
28 November 2025 in Extracellular Vesicles and Circulating Nucleic Acids
Urinary tract infections (UTIs) pose a significant public health challenge, affecting approximately 407 million people worldwide and causing substantial morbidity and approximately 237,000 deaths. Bacteria and fungi represent the most frequent causative microbes, leading to symptoms such as low abdominal pain, fever, frequent urination, hematuria, sepsis, inflammation of the bladder and kidney, and even death. In recent years, extracellular vesicles (EVs) have emerged as critical mediators of UTI pathogenesis. EVs are lipid bilayer nanoscale particles that carry DNA, RNA, enzymes, and other biomolecules. They can facilitate microbial colonization, immune modulation and evasion, tissue invasion, and antimicrobial agent resistance. This review summarizes current knowledge on the role of bacterial and fungal-derived EVs in UTIs, their mechanisms of action, and their potential therapeutic implications.